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Introduction
Fibroblast growth factor 21 (FGF21) is a recently identified
hormone that regulates metabolic homeostasis, with a
potential role as a stress hormone [1]. Critical illness is
hallmarked by insulin resistance and mitochondrial
damage, metabolic alterations that increase circulating
levels of FGF21 via the integrated stress response (ISR) [2].
Targeting normoglycemia during critical illness has shown
to attenuate mitochondrial damage in the liver, the main
source of FGF21 [3].
Objectives
We hypothesized that critical illness elevates FGF21 serum
concentrations, possibly induced by mitochondrial damage
and brought about by ISR mediators. We also hypothe-
sized that targeting normoglycemia during critical illness
suppresses FGF21 serum concentrations and fgf21 liver
expression, possibly by diminishing mitochondrial damage
in vital organs.
Methods
FGF21 serum concentrations were quantified in 405 fed
patients requiring intensive care for at least 7 days, who
were randomized to normoglycemia or tolerating hyper-
glycemia, and in 20 matched controls. In 39 rabbits, of
which 26 were critically ill and randomly assigned to
normoglycemia or hyperglycemia and 13 were healthy
controls, fgf21 expression was quantified on day 3 or day
7 in liver, kidney, muscle and adipose tissue. Correlations
between fgf21 expression and mitochondrial respiratory
chain enzyme complex activities and ISR mediators were
analyzed.
Results
In the critically ill patients, serum FGF21 concentrations
upon ICU admission were 8-fold higher than those in 20
healthy matched control subjects (p < 0.0001), decreased
with time, but always remained higher in non-survivors
than in survivors (p≤0.006). Maintaining normoglycemia
lowered serum FGF21 (p = 0.01), statistically explaining at
least part of its mortality benefit. Hepatic fgf21 expression
in critically ill rabbits was substantially increased on day 3
and day 7 (p≤0.01) and tightly correlated with mitochon-
drial dysfunction (all R2≥0.49, all p≤0.0006 for complex I
and V) on both days and with markers of the ISR on day 3
(R2≥0.73, p≤0.0001), which were all lowered by targeting
normoglycemia. In kidney, muscle and adipose tissue,
fgf21 expression was undetectable.
Conclusions
Critical illness was identified as a potent inducer of
serum FGF21 concentrations and liver fgf21 expression,
possibly driven at least in part by mitochondrial damage
and the ISR, which were all attenuated by targeting
normoglycemia.
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